Key result
CACS > 10 in asymptomatic diabetics is linked to ~30% lower risk of major events.
Why the study?
Does coronary plaque progression and baseline CACS predict adverse cardiovascular events in asymptomatic diabetic patients?
Observational (n=197)
No
Does coronary plaque progression and baseline CACS predict adverse cardiovascular events in asymptomatic diabetic patients?
Effect estimate: OR 0.701 (95% CI 0.612–0.836)
p-value: p=0.034
In asymptomatic diabetic patients, an increase in low-attenuation lipid-rich plaque volume independently predicts adverse cardiac events, whereas dense calcification progression appears inversely related to risk.
Higher CACS linked to lower event risk in asymptomatic diabetes; hypothesis-generating for plaque stability, needs prospective validation.
Asymptomatic patients with DM experienced plaque progression as well as progression to "overt or silent CAD". The relative increase in plaque volume was associated with subsequent cardiac events, and the coronary calcification seemed to be inversely related to the outcome in asymptomatic diabetic patients.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2019) conducted an observational in Diabetes Mellitus, Coronary Artery Disease (n=197). Standard of Care vs. Patients with CACS ≤10 (low risk) was evaluated on Composite endpoint of all-cause mortality, non-fatal myocardial infarction, and revascularization (OR 0.701, 95% CI 0.612–0.836, p=0.034). Asymptomatic diabetic patients with CACS > 10 had a cumulative event-free survival rate of 95%, compared to 81% for those with CACS ≤ 10, indicating a lower risk of adverse cardiac events associated with higher coronary calcification scores.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: